Capricor Therapeutics (CAPR) Other Working Capital Changes (2016 - 2024)

Capricor Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$1.1 million for Q4 2024.

• On a quarterly basis, Other Working Capital Changes rose 45.86% year-over-year to -$1.1 million in Q4 2024; TTM through Dec 2024 was -$12.3 million, a 286.1% decrease from a year earlier, with the FY2024 full-year figure at -$12.3 million, down 286.1% from the prior year.
• Other Working Capital Changes rose to -$1.1 million in Q4 2024 per CAPR's latest filing, from -$2.3 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $3.3 million in Q4 2025 and bottomed at -$979776.0 in Q1 2026.
• The 5-year median for Other Working Capital Changes is -$125418.0 (2023), against an average of $200491.1.
• Across the five-year window, Other Working Capital Changes plunged 288.66% in 2023 and soared 63.44% in 2024, its largest moves.
• Year by year, Other Working Capital Changes stood at -$959903.0 in 2022, then plunged by 117.53% to -$2.1 million in 2023, then surged by 45.86% to -$1.1 million in 2024.
• Per Business Quant, the three latest CAPR Other Working Capital Changes figures stand at -$1.1 million (Q4 2024), -$2.3 million (Q3 2024), and -$4.0 million (Q2 2024).